<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34079547</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>08</Day></DateCompleted><DateRevised><Year>2021</Year><Month>06</Month><Day>08</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><PubDate><Year>2021</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Quantification of Cytokine Storms During Virus Infections.</ArticleTitle><Pagination><StartPage>659419</StartPage><MedlinePgn>659419</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">659419</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2021.659419</ELocationID><Abstract><AbstractText>Highly pathogenic virus infections usually trigger cytokine storms, which may have adverse effects on vital organs and result in high mortalities. The two cytokines interleukin (IL)-4 and interferon (IFN)-&#x3b3; play key roles in the generation and regulation of cytokine storms. However, it is still unclear whether the cytokine with the largest induction amplitude is the same under different virus infections. It is unknown which is the most critical and whether there are any mathematical formulas that can fit the changing rules of cytokines. Three coronaviruses (SARS-CoV, MERS-CoV, and SARS-CoV-2), three influenza viruses (2009H1N1, H5N1 and H7N9), Ebola virus, human immunodeficiency virus, dengue virus, Zika virus, West Nile virus, hepatitis B virus, hepatitis C virus, and enterovirus 71 were included in this analysis. We retrieved the cytokine fold change (FC), viral load, and clearance rate data from these highly pathogenic virus infections in humans and analyzed the correlations among them. Our analysis showed that interferon-inducible protein (IP)-10, IL-6, IL-8 and IL-17 are the most common cytokines with the largest induction amplitudes. Equations were obtained: the maximum induced cytokine (max) FC = IFN-&#x3b3; FC &#xd7; (IFN-&#x3b3; FC/IL-4 FC) (if IFN-&#x3b3; FC/IL-4 FC &gt; 1); max FC = IL-4 FC (if IFN-&#x3b3; FC/IL-4 FC &lt; 1). For IFN-&#x3b3;-inducible infections, 1.30 &#xd7; log2 (IFN-&#x3b3; FC) = log10 (viral load) - 2.48 - 2.83 &#xd7; (clearance rate). The clinical relevance of cytokines and their antagonists is also discussed.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 Yuan, Jiang, Zhang, Fu, Hu and Li.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yuan</LastName><ForeName>Shu</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>College of Resources, Sichuan Agricultural University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Si-Cong</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>Chengdu KangHong Pharmaceutical Group Comp. Ltd., Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Zhong-Wei</ForeName><Initials>ZW</Initials><AffiliationInfo><Affiliation>College of Resources, Sichuan Agricultural University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fu</LastName><ForeName>Yu-Fan</ForeName><Initials>YF</Initials><AffiliationInfo><Affiliation>College of Resources, Sichuan Agricultural University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Jing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>School of Medicine, Northwest University, Xi'an, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Zi-Lin</ForeName><Initials>ZL</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Xijing Hospital, Medical University of the Air Force, Xi'an, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>05</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000080424" MajorTopicYN="N">Cytokine Release Syndrome</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018448" MajorTopicYN="Y">Models, Immunological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019562" MajorTopicYN="N">Viral Load</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014777" MajorTopicYN="N">Virus Diseases</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">IFN-&#x3b3;</Keyword><Keyword MajorTopicYN="N">IL-4</Keyword><Keyword MajorTopicYN="N">clearance rate</Keyword><Keyword MajorTopicYN="N">cytokine storm</Keyword><Keyword MajorTopicYN="N">viral load</Keyword></KeywordList><CoiStatement>S-CJ was employed by the Chengdu KangHong Pharmaceutical Group Comp. Ltd. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>1</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>5</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>6</Month><Day>3</Day><Hour>6</Hour><Minute>40</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>6</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>5</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34079547</ArticleId><ArticleId IdType="pmc">PMC8165266</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2021.659419</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Chan MC, Cheung CY, Chui WH, Tsao SW, Nicholls JM, Chan YO, et al. . Proinflammatory Cytokine Responses Induced by Influenza A (H5n1) Viruses in Primary Human Alveolar and Bronchial Epithelial Cells. Respir Res (2005) 6:135. &#xa0;10.1186/1465-9921-6-135</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1465-9921-6-135</ArticleId><ArticleId IdType="pmc">PMC1318487</ArticleId><ArticleId IdType="pubmed">16283933</ArticleId></ArticleIdList></Reference><Reference><Citation>Cilloniz C, Pantin-Jackwood MJ, Ni C, Goodman AG, Peng X, Proll SC, et al. . Lethal Dissemination of H5N1 Influenza Virus is Associated With Dysregulation of Inflammation and Lipoxin Signaling in a Mouse Model of Infection. J Virol (2010) 84:7613&#x2013;24. &#xa0;10.1128/JVI.00553-10</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00553-10</ArticleId><ArticleId IdType="pmc">PMC2897611</ArticleId><ArticleId IdType="pubmed">20504916</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukuyama S, Kawaoka Y. The Pathogenesis of Influenza Virus Infections: The Contributions of Virus and Host Factors. Curr Opin Immunol (2011) 23:481&#x2013;6. &#xa0;10.1016/j.coi.2011.07.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coi.2011.07.016</ArticleId><ArticleId IdType="pmc">PMC3163725</ArticleId><ArticleId IdType="pubmed">21840185</ArticleId></ArticleIdList></Reference><Reference><Citation>Perrone LA, Plowden JK, Garcia-Sastre A, Katz JM, Tumpey TM. H5N1 and 1918 Pandemic Influenza Virus Infection Results in Early and Excessive Infiltration of Macrophages and Neutrophils in the Lungs of Mice. PloS Pathog (2008) 4:e1000115. &#xa0;10.1371/journal.ppat.1000115</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1000115</ArticleId><ArticleId IdType="pmc">PMC2483250</ArticleId><ArticleId IdType="pubmed">18670648</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong CK, Lam CW, Wu AK, Ip WK, Lee NL, Chan IH, et al. . Plasma Inflammatory Cytokines and Chemokines in Severe Acute Respiratory Syndrome. Clin Exp Immunol (2004) 136:95&#x2013;103. &#xa0;10.1111/j.1365-2249.2004.02415.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2249.2004.02415.x</ArticleId><ArticleId IdType="pmc">PMC1808997</ArticleId><ArticleId IdType="pubmed">15030519</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahallawi WH, Khabour OF, Zhang Q, Makhdoum HM, Suliman BA. Mers-Cov Infection in Humans is Associated With a Pro-Inflammatory Th1 and Th17 Cytokine Profile. Cytokine (2018) 104:8&#x2013;13. &#xa0;10.1016/j.cyto.2018.01.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2018.01.025</ArticleId><ArticleId IdType="pmc">PMC7129230</ArticleId><ArticleId IdType="pubmed">29414327</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Gao H, Liang W, Tang L, Yang Y, Wu X, et al. . Efficacy of Oseltamivir-Peramivir Combination Therapy Compared to Oseltamivir Monotherapy for Influenza A (H7n9) Infection: A Retrospective Study. BMC Infect Dis (2016) 16:76. &#xa0;10.1186/s12879-016-1383-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-016-1383-8</ArticleId><ArticleId IdType="pmc">PMC4748590</ArticleId><ArticleId IdType="pubmed">26864456</ArticleId></ArticleIdList></Reference><Reference><Citation>Duchamp MB, Casalegno JS, Gillet Y, Frobert E, Bernard E, Escuret V, et al. . Pandemic A(H1N1)2009 Influenza Virus Detection by Real Time RT-PCR: Is Viral Quantification Useful? Clin Microbiol Infect (2010) 16:317&#x2013;21. &#xa0;10.1111/j.1469-0691.2010.03169.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1469-0691.2010.03169.x</ArticleId><ArticleId IdType="pubmed">20121827</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu H, Liao Q, Yuan Y, Zhou L, Xiang N, Huai Y, et al. . Effectiveness of Oseltamivir on Disease Progression and Viral Rna Shedding in Patients With Mild Pandemic 2009 Influenza A H1n1: Opportunistic Retrospective Study of Medical Charts in China. BMJ (2010) 341:c4779. &#xa0;10.1136/bmj.c4779</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.c4779</ArticleId><ArticleId IdType="pmc">PMC2947622</ArticleId><ArticleId IdType="pubmed">20876641</ArticleId></ArticleIdList></Reference><Reference><Citation>Bermejo-Martin JF, Ortiz de Lejarazu R, Pumarola T, Rello J, Almansa R, Ram&#xed;rez P, et al. . Th1 and Th17 Hypercytokinemia as Early Host Response Signature in Severe Pandemic Influenza. Crit Care (2009) 13:R201. &#xa0;10.1186/cc8208</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc8208</ArticleId><ArticleId IdType="pmc">PMC2811892</ArticleId><ArticleId IdType="pubmed">20003352</ArticleId></ArticleIdList></Reference><Reference><Citation>Kerber R, Krumkamp R, Korva M, Rieger T, Wurr S, Duraffour S, et al. . Kinetics of Soluble Mediators of the Host Response in Ebola Virus Disease. J Infect Dis (2018) 218(S5):S496&#x2013;503. &#xa0;10.1093/infdis/jiy429</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiy429</ArticleId><ArticleId IdType="pmc">PMC6249596</ArticleId><ArticleId IdType="pubmed">30101349</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong X, Liu Z, Jiang L, Tao R, Liu W, Zhang L, et al. . Dynamic Changes of Th1/Th2/Th17 Cytokines and Human Beta Defensin 2 in HIV-infected Patients With Oral Candidiasis During the First Year of Highly Active Anti-Retroviral Therapy. Arch Oral Biol (2018) 92:62&#x2013;7. &#xa0;10.1016/j.archoralbio.2018.05.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.archoralbio.2018.05.003</ArticleId><ArticleId IdType="pubmed">29753928</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Liu H, Wang L, Yang F, Hu Y, Ren X, et al. . Comparative Study of the Cytokine/Chemokine Response in Children With Differing Disease Severity in Enterovirus 71-Induced Hand, Foot, and Mouth Disease. PloS One (2013) 8:e67430. &#xa0;10.1371/journal.pone.0067430</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0067430</ArticleId><ArticleId IdType="pmc">PMC3696071</ArticleId><ArticleId IdType="pubmed">23840697</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang SY, Xu MY, Xu HM, Li XJ, Ding SJ, Wang XJ, et al. . Immunologic Characterization of Cytokine Responses to Enterovirus 71 and Coxsackievirus A16 Infection in Children. Medicine (2015) 94:e1137. &#xa0;10.1097/MD.0000000000001137</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000001137</ArticleId><ArticleId IdType="pmc">PMC4504596</ArticleId><ArticleId IdType="pubmed">26166120</ArticleId></ArticleIdList></Reference><Reference><Citation>Paludan SR. Interleukin-4 and Interferon-Gamma: The Quintessence of a Mutual Antagonistic Relationship. Scand J Immunol (1998) 48:459&#x2013;68. &#xa0;10.1046/j.1365-3083.1998.00435.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-3083.1998.00435.x</ArticleId><ArticleId IdType="pubmed">9822252</ArticleId></ArticleIdList></Reference><Reference><Citation>Infante-Duart C, Kamradt T. Thl/Th2 Balance in Infection. Springer Semin Immunopathol (1999) 21:317&#x2013;38. 10.1007/BF00812260</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00812260</ArticleId><ArticleId IdType="pubmed">10666776</ArticleId></ArticleIdList></Reference><Reference><Citation>Sissoko D, Duraffour S, Kerber R, Kolie JS, Beavogui AH, Camara AM, et al. . Persistence and Clearance of Ebola Virus RNA From Seminal Fluid of Ebola Virus Disease Survivors: A Longitudinal Analysis and Modelling Study. Lancet Glob Health (2017) 5:e80&#x2013;8. &#xa0;10.1016/S2214-109X(16)30243-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2214-109X(16)30243-1</ArticleId><ArticleId IdType="pubmed">27955791</ArticleId></ArticleIdList></Reference><Reference><Citation>Tricou V, Minh NN, Farrar J, Tran HT, Simmons CP. Kinetics of Viremia and NS1 Antigenemia are Shaped by Immune Status and Virus Serotype in Adults With Dengue. PloS Negl Trop Dis (2011) 5:e1309. &#xa0;10.1371/journal.pntd.0001309</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0001309</ArticleId><ArticleId IdType="pmc">PMC3167785</ArticleId><ArticleId IdType="pubmed">21909448</ArticleId></ArticleIdList></Reference><Reference><Citation>Hofer H, Watkins-Riedel T, Janata O, Penner E, Holzmann H, Steindl-Munda P, et al. . Spontaneous Viral Clearance in Patients With Acute Hepatitis C can be Predicted by Repeated Measurements of Serum Viral Load. Hepatology (2003) 37:60&#x2013;4. &#xa0;10.1053/jhep.2003.50019</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/jhep.2003.50019</ArticleId><ArticleId IdType="pubmed">12500189</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomson EC, Fleming VM, Main J, Klenerman P, Weber J, Eliahoo J, et al. . Predicting Spontaneous Clearance of Acute Hepatitis C Virus in a Large Cohort of HIV-1-infected Men. Gut (2011) 60:837&#x2013;45. &#xa0;10.1136/gut.2010.217166</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gut.2010.217166</ArticleId><ArticleId IdType="pmc">PMC3095479</ArticleId><ArticleId IdType="pubmed">21139063</ArticleId></ArticleIdList></Reference><Reference><Citation>To KK, Tsang OT, Leung WS, Tam AR, Wu TC, Lung DC, et al. . Temporal Profiles of Viral Load in Posterior Oropharyngeal Saliva Samples and Serum Antibody Responses During Infection by SARS-CoV-2: An Observational Cohort Study. Lancet Infect Dis (2020) 20:565&#x2013;74. &#xa0;10.1016/S1473-3099(20)30196-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30196-1</ArticleId><ArticleId IdType="pmc">PMC7158907</ArticleId><ArticleId IdType="pubmed">32213337</ArticleId></ArticleIdList></Reference><Reference><Citation>Copaescu A, Smibert O, Gibson A, Phillips EJ, Trubiano JA. The Role of IL-6 and Other Mediators in the Cytokine Storm Associated With SARS-CoV-2 Infection. J Allergy Clin Immunol (2020) 146:518&#x2013;34.e1. &#xa0;10.1016/j.jaci.2020.07.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2020.07.001</ArticleId><ArticleId IdType="pmc">PMC7471766</ArticleId><ArticleId IdType="pubmed">32896310</ArticleId></ArticleIdList></Reference><Reference><Citation>Gubernatorova EO, Gorshkova EA, Polinova AI, Drutskaya MS. Il-6: Relevance for Immunopathology of SARS-Cov-2. Cytokine Growth Factor Rev (2020) 53:13&#x2013;24. &#xa0;10.1016/j.cytogfr.2020.05.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cytogfr.2020.05.009</ArticleId><ArticleId IdType="pmc">PMC7237916</ArticleId><ArticleId IdType="pubmed">32475759</ArticleId></ArticleIdList></Reference><Reference><Citation>Masi&#xe1; M, Fern&#xe1;ndez-Gonz&#xe1;lez M, Padilla S, Ortega P, Garc&#xed;a JA, Agull&#xf3; V, et al. . Impact of Interleukin-6 Blockade With Tocilizumab on SARS-CoV-2 Viral Kinetics and Antibody Responses in Patients With Covid-19: A Prospective Cohort Study. EBioMedicine (2020) 60:102999. &#xa0;10.1016/j.ebiom.2020.102999</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2020.102999</ArticleId><ArticleId IdType="pmc">PMC7492814</ArticleId><ArticleId IdType="pubmed">32950003</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. . Clinical Features of Patients Infected With 2019 Novel Coronavirus in Wuhan, China. Lancet (2020) 395:497&#x2013;506. &#xa0;10.1016/S0140-6736(20)30183-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30183-5</ArticleId><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Shata MTM, Abdel-Hameed EA, Rouster SD, Yu L, Liang M, Song E, et al. . HBV and HIV/HBV Infected Patients Have Distinct Immune Exhaustion and Apoptotic Serum Biomarker Profiles. Pathog Immun (2019) 4:39&#x2013;65. &#xa0;10.20411/pai.v4i1.267</Citation><ArticleIdList><ArticleId IdType="doi">10.20411/pai.v4i1.267</ArticleId><ArticleId IdType="pmc">PMC6388707</ArticleId><ArticleId IdType="pubmed">30815625</ArticleId></ArticleIdList></Reference><Reference><Citation>Poli G, Biswas P, Fauci AS. Interferons in the Pathogenesis and Treatment of Human Immunodeficiency Virus Infection. Antiviral Res (1994) 24:221&#x2013;33. &#xa0;10.1016/0166-3542(94)90069-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0166-3542(94)90069-8</ArticleId><ArticleId IdType="pubmed">7526793</ArticleId></ArticleIdList></Reference><Reference><Citation>Towner JS, Rollin PE, Bausch DG, Sanchez A, Crary SM, Vincent M, et al. . Rapid Diagnosis of Ebola Hemorrhagic Fever by Reverse transcription-PCR in an Outbreak Setting and Assessment of Patient Viral Load as a Predictor of Outcome. J Virol (2004) 78:4330&#x2013;41. &#xa0;10.1128/jvi.78.8.4330-4341.2004</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.78.8.4330-4341.2004</ArticleId><ArticleId IdType="pmc">PMC374287</ArticleId><ArticleId IdType="pubmed">15047846</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Z, Liu Y, Xu L, Guan W, Zhang X, Qi T, et al. . Extra-Pulmonary Viral Shedding in H7N9 Avian Influenza Patients. J Clin Virol (2015) 69:30&#x2013;2. &#xa0;10.1016/j.jcv.2015.05.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2015.05.013</ArticleId><ArticleId IdType="pubmed">26209373</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y, Wong G, Yang L, Tan S, Li J, Bai B, et al. . Comparison Between Human Infections Caused by Highly and Low Pathogenic H7N9 Avian Influenza Viruses in Wave Five: Clinical and Virological Findings. J Infect (2019) 78:241&#x2013;8. &#xa0;10.1016/j.jinf.2019.01.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2019.01.005</ArticleId><ArticleId IdType="pubmed">30664912</ArticleId></ArticleIdList></Reference><Reference><Citation>Seymour RM, Henderson B. Pro-Inflammatory&#x2013;Anti-Inflammatory Cytokine Dynamics Mediated by Cytokine-Receptor Dynamics in Monocytes. IMA J Math Appl Med Biol (2001) 18:159&#x2013;92. 10.1093/imammb/18.2.159</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/imammb/18.2.159</ArticleId><ArticleId IdType="pubmed">11453467</ArticleId></ArticleIdList></Reference><Reference><Citation>Yiu HH, Graham AL, Stengel RF. Dynamics of a Cytokine Storm. PloS One (2012) 7:e45027. &#xa0;10.1371/journal.pone.0045027</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0045027</ArticleId><ArticleId IdType="pmc">PMC3462188</ArticleId><ArticleId IdType="pubmed">23049677</ArticleId></ArticleIdList></Reference><Reference><Citation>Jarrett AM, Cogan NG, Shirtliff ME. Modelling the Interaction Between the Host Immune Response, Bacterial Dynamics and Inflammatory Damage in Comparison With Immunomodulation and Vaccination Experiments. Math Med Biol (2015) 32:285&#x2013;306. &#xa0;10.1093/imammb/dqu008</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/imammb/dqu008</ArticleId><ArticleId IdType="pmc">PMC4416065</ArticleId><ArticleId IdType="pubmed">24814512</ArticleId></ArticleIdList></Reference><Reference><Citation>Waito M, Walsh SR, Rasiuk A, Bridle BW, Willms AR. A Mathematical Model of Cytokine Dynamics During a Cytokine Storm. In: B&#xe9;lair J, Frigaard I, Kunze H, Makarov R, Melnik R, Spiteri R, editors. Mathematical and Computational Approaches in Advancing Modern Science and Engineering. Cham, Switzerland: Springer, Cham; (2016). p. 331&#x2013;9. &#xa0;10.1007/978-3-319-30379-6_31</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-319-30379-6_31</ArticleId></ArticleIdList></Reference><Reference><Citation>Waters RS, Perry JSA, Han S, Bielekova B, Gedeon T. The Effects of Interleukin-2 on Immune Response Regulation. Math Med Biol (2018) 35:79&#x2013;119. &#xa0;10.1093/imammb/dqw021</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/imammb/dqw021</ArticleId><ArticleId IdType="pmc">PMC5576036</ArticleId><ArticleId IdType="pubmed">28339682</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang W, Jang S, Jonsson CB, Allen LJS. Models of Cytokine Dynamics in the Inflammatory Response of Viral Zoonotic Infectious Diseases. Math Med Biol (2019) 36:269&#x2013;95. &#xa0;10.1093/imammb/dqy009</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/imammb/dqy009</ArticleId><ArticleId IdType="pmc">PMC7108568</ArticleId><ArticleId IdType="pubmed">29961899</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>